cimr.org
域名年龄: 23年11个月29天HTTP/1.1 301 永久重定向 访问时间:2015年02月17日 06:09:06 目标网址:http://www.cimr.org/ 文件大小:228 Keep-Alive: timeout=5, max=100 连接:Keep-Alive 类型:text/html; charset=iso-8859-1 HTTP/1.1 200 OK 访问时间:2015年02月17日 06:09:06 缓存控制:no-store, 不缓存,必须更新, post-check=0, pre-check=0 其他指令:不缓存 设置Cookie:CMSSESSIDc6b7ceab=bpuhbf1ql6bupcskngimhndko4; path=/ 修改日期:2015年02月17日 06:09:08 动作:Accept-Encoding Content-Encoding: gzip 文件大小:4218 Keep-Alive: timeout=5, max=100 连接:Keep-Alive 类型:text/html; charset=utf-8 网站编码:utf-8
California Institute for Medical Research Quick links: content, navigation, search. Menu Home About CIMR Research & Researchers Grants Administration Facilities & Equipment Directions News CIMR Nationally Recognized Research More than 300 research programs have been conducted at CIMR by award winning researchers. This has resulted in nationally recognized discoveries in medicine and medical care. These have included: improving the treatment of fungal diseases such as Valley Fever preventing recurrent heart attack and stroke developing an animal model of Parkinson’s disease studying the influence of genetics on developing cancer. identifying naturally-occuring organic compounds with anti-cancer activity (from nutritional studies in cancer) investigating immune restoration by biological antioxidants (such as lipoic acid) in AIDS (from nutritional studies in AIDS) CIMR researchers have also advanced the understanding of how the brain and spinal cord respond to neurological disorders, and developed a direct physiologic measurement of neurological processes that are critical to recovery from stroke and traumatic brain injury. In addition, HIV physician-researchers have provided SCVMC patients access to clinical trial studies, including adherence and treatment strategies, prophylaxis and treatment of various opportunistic infections, and viral vaccine trials. The Neurology Research Laboratory has completed a series of experiments demonstrating substantial neuroplasticity of the part of the adult brain that produces vision. These findings suggest an intrinsic mechanism that can potentially help repair visual loss after stroke or injury to the visual brain. The Infectious Diseases Laboratory continues to make significant progress in the treatment of fungal infections, performing in vitro and in vivo studies on novel compounds and testing licensed conventional antifungals alone and in combination. Studies of molecular epidemiology of the mycoses, of host defenses against fungal infections (including the possibility of immunomodulation) and of vaccine development are areas of extensive effort. Research Highlight Injecting mice with simple baker’s yeast protects against the fatal fungal infection, aspergillosis, according to research published in the Journal of Medical Microbiology. The work could lead to the development of a human vaccine that protects immunocompromised people against a range of life-threatening fungal infections, for which current therapy often fails. Researchers from the California Institute for Medical Research (Dr. David Stevens' research team), Santa Clara Valley Medical Center and Stanford University gave mice three injections of killed Saccharomyces (baker’s yeast), one week apart. Vaccinated mice were able to survive high doses of Aspergillus – the fungus that causes aspergillosis. Mice that survived also showed a reduced infection load in their organs. To view full press release, click here David Stevens, MD,
© 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询
2024-08-13 01:31, Process in 0.0092 second.